ROBERT W DUGGAN Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ROBERT W DUGGAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ROBERT W DUGGAN. ROBERT W DUGGAN is Chairman and CEO in PHARMACYCLICS INC ($PCYC) and 10% Owner in Achaogen Inc ($AKAO) and Chief Executive Officer in Summit Therapeutics Inc. ($SMMT) and 10% Owner in Pulse Biosciences, Inc. ($PLSE) and Director in Pulse Biosciences, Inc. ($PLSE).
Latest Insider Trading Transactions of ROBERT W DUGGAN
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AKAO, PCYC, PLSE, SMMT
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 14 2021 | SMMT | Summit Therapeutic ... | DUGGAN ROBERT W | Chief Executive Off ... | Buy | P | 5.24 | 11,365,921 | 59,557,426 | 67,662,454 | 56.3 M to 67.7 M (+20.19 %) |
Dec 30 2020 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | Director | Option Exercise | X | 7.01 | 8,214 | 57,580 | 0 | |
Dec 30 2020 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | Director | Option Exercise | X | 7.01 | 376,065 | 2,636,216 | 0 | |
Dec 30 2020 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | Director | Buy | X | 7.01 | 8,214 | 57,580 | 330,019 | 321.8 K to 330 K (+2.55 %) |
Dec 30 2020 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | Director | Option Exercise | X | 7.01 | 8,214 | 57,580 | 0 | |
Dec 30 2020 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | Director | Buy | X | 7.01 | 376,065 | 2,636,216 | 11,659,781 | 11.3 M to 11.7 M (+3.33 %) |
Dec 30 2020 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | Director | Option Exercise | X | 7.01 | 376,065 | 2,636,216 | 0 | |
Dec 30 2020 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | Director | Buy | X | 7.01 | 8,214 | 57,580 | 330,019 | 321.8 K to 330 K (+2.55 %) |
Dec 30 2020 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | Director | Buy | X | 7.01 | 376,065 | 2,636,216 | 11,659,781 | 11.3 M to 11.7 M (+3.33 %) |
Nov 10 2020 | SMMT | Summit Therapeutic ... | DUGGAN ROBERT W | Chief Executive Off ... | Buy | P | 3.34 | 14,071,856 | 46,999,999 | 56,296,533 | 42.2 M to 56.3 M (+33.33 %) |
Jun 17 2020 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | Director | Option Exercise | P | 7.01 | 8,214 | 57,580 | 8,214 | |
Jun 17 2020 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | Director | Option Exercise | P | 7.01 | 376,065 | 2,636,216 | 376,065 | |
Jun 17 2020 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | Director | Buy | X | 7.01 | 54,761 | 383,875 | 321,805 | 267 K to 321.8 K (+20.51 %) |
Jun 17 2020 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | Director | Buy | X | 7.01 | 2,507,112 | 17,574,855 | 11,283,716 | 8.8 M to 11.3 M (+28.57 %) |
May 19 2020 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | Director | Option Exercise | A | 10.66 | 20,347 | 216,899 | 20,347 | |
May 19 2020 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | Director | Option Exercise | A | 10.66 | 20,000 | 213,200 | 20,000 | |
May 17 2019 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | Director | Option Exercise | A | 13.03 | 13,124 | 171,006 | 13,124 | |
May 17 2019 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | Director | Option Exercise | A | 13.03 | 15,000 | 195,450 | 15,000 | |
Mar 20 2019 | AKAO | Achaogen, Inc. | DUGGAN ROBERT W | 10% Owner | Sell | S | 0.53 | 50,000 | 26,500 | 5,555,414 | 5.6 M to 5.6 M (-0.89 %) |
Mar 20 2019 | AKAO | Achaogen, Inc. | DUGGAN ROBERT W | 10% Owner | Sell | S | 0.53 | 956,009 | 506,685 | 5,605,414 | 6.6 M to 5.6 M (-14.57 %) |
Mar 20 2019 | AKAO | Achaogen, Inc. | DUGGAN ROBERT W | 10% Owner | Sell | S | 0.56 | 271,879 | 152,252 | 6,561,423 | 6.8 M to 6.6 M (-3.98 %) |
Mar 13 2019 | AKAO | Achaogen, Inc. | DUGGAN ROBERT W | 10% Owner | Sell | S | 0.59 | 1,199,930 | 707,959 | 6,833,302 | 8 M to 6.8 M (-14.94 %) |
Mar 13 2019 | AKAO | Achaogen, Inc. | DUGGAN ROBERT W | 10% Owner | Sell | S | 0.61 | 633,975 | 386,725 | 8,033,232 | 8.7 M to 8 M (-7.31 %) |
Mar 13 2019 | AKAO | Achaogen, Inc. | DUGGAN ROBERT W | 10% Owner | Sell | S | 0.63 | 520,102 | 327,664 | 8,667,207 | 9.2 M to 8.7 M (-5.66 %) |
Jan 09 2019 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | Director | Option Exercise | A | 13.22 | 4,444 | 58,750 | 4,444 | |
Dec 17 2018 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | Director | Buy | X | 12.57 | 232,044 | 2,915,818 | 267,044 | 35 K to 267 K (+662.98 %) |
Dec 17 2018 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | Director | Buy | X | 12.57 | 2,914,182 | 36,619,028 | 8,776,604 | 5.9 M to 8.8 M (+49.71 %) |
Dec 12 2018 | AKAO | Achaogen, Inc. | DUGGAN ROBERT W | 10% Owner | Buy | P | 1.65 | 306,848 | 505,010 | 9,187,309 | 8.9 M to 9.2 M (+3.46 %) |
Dec 12 2018 | AKAO | Achaogen, Inc. | DUGGAN ROBERT W | 10% Owner | Buy | P | 1.60 | 436,500 | 697,789 | 8,880,461 | 8.4 M to 8.9 M (+5.17 %) |
Dec 11 2018 | AKAO | Achaogen, Inc. | DUGGAN ROBERT W | 10% Owner | Buy | P | 1.40 | 22,431 | 31,394 | 8,443,961 | 8.4 M to 8.4 M (+0.27 %) |
Nov 27 2018 | AKAO | Achaogen, Inc. | DUGGAN ROBERT W | 10% Owner | Buy | P | 1.68 | 77,585 | 129,963 | 8,421,530 | 8.3 M to 8.4 M (+0.93 %) |
Nov 27 2018 | AKAO | Achaogen, Inc. | DUGGAN ROBERT W | 10% Owner | Buy | P | 1.89 | 80,175 | 151,643 | 8,343,945 | 8.3 M to 8.3 M (+0.97 %) |
Nov 23 2018 | AKAO | Achaogen, Inc. | DUGGAN ROBERT W | 10% Owner | Buy | P | 1.93 | 231,495 | 446,947 | 8,263,770 | 8 M to 8.3 M (+2.88 %) |
Nov 20 2018 | AKAO | Achaogen, Inc. | DUGGAN ROBERT W | 10% Owner | Buy | P | 1.62 | 4,648 | 7,525 | 8,032,275 | 8 M to 8 M (+0.06 %) |
May 24 2018 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | Director | Option Exercise | A | 15.27 | 15,000 | 229,050 | 15,000 | |
May 15 2018 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | Director | Buy | P | 23.16 | 21,353 | 494,535 | 5,862,422 | 5.8 M to 5.9 M (+0.37 %) |
May 07 2018 | AKAO | Achaogen Inc | DUGGAN ROBERT W | 10% Owner | Buy | P | 11.43 | 100,255 | 1,146,316 | 100,255 | 0 to 100.3 K |
May 07 2018 | AKAO | Achaogen Inc | DUGGAN ROBERT W | 10% Owner | Buy | P | 11.54 | 30,000 | 346,338 | 30,000 | 0 to 30 K |
May 07 2018 | AKAO | Achaogen Inc | DUGGAN ROBERT W | 10% Owner | Buy | P | 11.31 | 846,625 | 9,579,477 | 8,027,627 | 7.2 M to 8 M (+11.79 %) |
Apr 27 2018 | AKAO | Achaogen Inc | DUGGAN ROBERT W | 10% Owner | Buy | P | 12.96 | 102,849 | 1,333,160 | 7,181,002 | 7.1 M to 7.2 M (+1.45 %) |
Apr 27 2018 | AKAO | Achaogen Inc | DUGGAN ROBERT W | 10% Owner | Buy | P | 12.96 | 50,000 | 647,755 | 7,078,153 | 7 M to 7.1 M (+0.71 %) |
Apr 27 2018 | AKAO | Achaogen Inc | DUGGAN ROBERT W | 10% Owner | Buy | P | 13.02 | 77,247 | 1,005,949 | 7,028,153 | 7 M to 7 M (+1.11 %) |
Apr 23 2018 | AKAO | Achaogen Inc | DUGGAN ROBERT W | 10% Owner | Buy | P | 13.07 | 132,487 | 1,730,969 | 6,950,906 | 6.8 M to 7 M (+1.94 %) |
Apr 23 2018 | AKAO | Achaogen Inc | DUGGAN ROBERT W | 10% Owner | Buy | P | 13.23 | 216,150 | 2,860,421 | 6,818,419 | 6.6 M to 6.8 M (+3.27 %) |
Apr 23 2018 | AKAO | Achaogen Inc | DUGGAN ROBERT W | 10% Owner | Buy | P | 12.76 | 119,700 | 1,527,264 | 6,602,269 | 6.5 M to 6.6 M (+1.85 %) |
Apr 04 2018 | AKAO | Achaogen Inc | DUGGAN ROBERT W | 10% Owner | Buy | P | 12.44 | 47,361 | 588,977 | 6,482,569 | 6.4 M to 6.5 M (+0.74 %) |
Apr 04 2018 | AKAO | Achaogen Inc | DUGGAN ROBERT W | 10% Owner | Buy | P | 12.46 | 24,100 | 300,240 | 6,435,208 | 6.4 M to 6.4 M (+0.38 %) |
Apr 04 2018 | AKAO | Achaogen Inc | DUGGAN ROBERT W | 10% Owner | Buy | P | 12.51 | 20,000 | 250,202 | 6,411,108 | 6.4 M to 6.4 M (+0.31 %) |
Mar 30 2018 | AKAO | Achaogen Inc | DUGGAN ROBERT W | 10% Owner | Buy | P | 12.44 | 30,000 | 373,095 | 6,391,108 | 6.4 M to 6.4 M (+0.47 %) |
Mar 21 2018 | AKAO | Achaogen Inc | DUGGAN ROBERT W | 10% Owner | Buy | P | 11.09 | 25,000 | 277,155 | 6,361,108 | 6.3 M to 6.4 M (+0.39 %) |
Mar 21 2018 | AKAO | Achaogen Inc | DUGGAN ROBERT W | 10% Owner | Buy | P | 11.20 | 11,300 | 126,557 | 6,336,108 | 6.3 M to 6.3 M (+0.18 %) |
Mar 16 2018 | AKAO | Achaogen Inc | DUGGAN ROBERT W | 10% Owner | Buy | P | 11.23 | 30,000 | 336,756 | 6,324,808 | 6.3 M to 6.3 M (+0.48 %) |
Mar 16 2018 | AKAO | Achaogen Inc | DUGGAN ROBERT W | 10% Owner | Buy | P | 11.57 | 19,660 | 227,488 | 6,294,808 | 6.3 M to 6.3 M (+0.31 %) |
Mar 13 2018 | AKAO | Achaogen Inc | DUGGAN ROBERT W | 10% Owner | Buy | P | 11.39 | 20,000 | 227,802 | 6,275,148 | 6.3 M to 6.3 M (+0.32 %) |
Mar 13 2018 | AKAO | Achaogen Inc | DUGGAN ROBERT W | 10% Owner | Buy | P | 11.41 | 50,000 | 570,520 | 6,255,148 | 6.2 M to 6.3 M (+0.81 %) |
Mar 02 2018 | AKAO | Achaogen Inc | DUGGAN ROBERT W | 10% Owner | Buy | P | 10.14 | 96,790 | 981,683 | 6,205,148 | 6.1 M to 6.2 M (+1.58 %) |
Mar 02 2018 | AKAO | Achaogen Inc | DUGGAN ROBERT W | 10% Owner | Buy | P | 10.33 | 410,606 | 4,243,285 | 6,108,358 | 5.7 M to 6.1 M (+7.21 %) |
Mar 02 2018 | AKAO | Achaogen Inc | DUGGAN ROBERT W | 10% Owner | Buy | P | 10.70 | 20,000 | 213,928 | 5,697,752 | 5.7 M to 5.7 M (+0.35 %) |
Feb 15 2018 | AKAO | Achaogen Inc | DUGGAN ROBERT W | 10% Owner | Buy | P | 10.96 | 9,442 | 103,487 | 5,677,752 | 5.7 M to 5.7 M (+0.17 %) |
Feb 15 2018 | AKAO | Achaogen Inc | DUGGAN ROBERT W | 10% Owner | Buy | P | 10.97 | 558 | 6,119 | 5,668,310 | 5.7 M to 5.7 M (+0.01 %) |
Jan 05 2018 | AKAO | Achaogen Inc | DUGGAN ROBERT W | 10% Owner | Buy | P | 11.51 | 50,000 | 575,500 | 5,667,752 | 5.6 M to 5.7 M (+0.89 %) |
Jan 05 2018 | AKAO | Achaogen Inc | DUGGAN ROBERT W | 10% Owner | Buy | P | 10.89 | 15,000 | 163,353 | 5,617,752 | 5.6 M to 5.6 M (+0.27 %) |
Dec 20 2017 | AKAO | Achaogen Inc | DUGGAN ROBERT W | 10% Owner | Buy | P | 11.13 | 95,012 | 1,057,493 | 5,602,752 | 5.5 M to 5.6 M (+1.73 %) |
Dec 13 2017 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | Director | Buy | P | 22.44 | 20,556 | 461,277 | 5,841,069 | 5.8 M to 5.8 M (+0.35 %) |
Nov 06 2017 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | Director | Option Exercise | A | 23.08 | 65,000 | 1,500,200 | 65,000 | |
Oct 23 2017 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | 10% Owner | Buy | P | 22.79 | 22,901 | 521,868 | 5,820,513 | 5.8 M to 5.8 M (+0.40 %) |
Sep 26 2017 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | 10% Owner | Buy | P | 15.02 | 2,000,000 | 30,040,000 | 5,797,612 | 3.8 M to 5.8 M (+52.66 %) |
Sep 18 2017 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | 10% Owner | Buy | P | 15.50 | 7,497 | 116,175 | 3,797,612 | 3.8 M to 3.8 M (+0.20 %) |
Sep 18 2017 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | 10% Owner | Buy | P | 15.12 | 23,703 | 358,283 | 3,790,115 | 3.8 M to 3.8 M (+0.63 %) |
Sep 18 2017 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | 10% Owner | Buy | P | 16.22 | 500 | 8,108 | 3,766,412 | 3.8 M to 3.8 M (+0.01 %) |
Sep 18 2017 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | 10% Owner | Buy | P | 15.70 | 125,000 | 1,963,088 | 3,765,912 | 3.6 M to 3.8 M (+3.43 %) |
Sep 18 2017 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | 10% Owner | Buy | P | 14.38 | 71,598 | 1,029,515 | 3,640,912 | 3.6 M to 3.6 M (+2.01 %) |
Sep 18 2017 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | 10% Owner | Buy | P | 14.57 | 47,450 | 691,332 | 3,569,314 | 3.5 M to 3.6 M (+1.35 %) |
Sep 18 2017 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | 10% Owner | Buy | P | 13.90 | 53,820 | 748,136 | 3,521,864 | 3.5 M to 3.5 M (+1.55 %) |
Sep 18 2017 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | 10% Owner | Buy | P | 12.77 | 30,050 | 383,859 | 3,468,044 | 3.4 M to 3.5 M (+0.87 %) |
Sep 18 2017 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | 10% Owner | Buy | P | 11.66 | 50,300 | 586,609 | 3,437,994 | 3.4 M to 3.4 M (+1.48 %) |
Aug 03 2017 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | 10% Owner | Buy | P | 23.70 | 68,964 | 1,634,723 | 3,387,694 | 3.3 M to 3.4 M (+2.08 %) |
Aug 03 2017 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | 10% Owner | Buy | P | 25.12 | 38,290 | 961,883 | 3,318,730 | 3.3 M to 3.3 M (+1.17 %) |
Aug 03 2017 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | 10% Owner | Buy | P | 24.37 | 14,710 | 358,512 | 3,280,440 | 3.3 M to 3.3 M (+0.45 %) |
Aug 03 2017 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | 10% Owner | Buy | P | 24.02 | 6,868 | 164,956 | 3,265,730 | 3.3 M to 3.3 M (+0.21 %) |
Aug 03 2017 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | 10% Owner | Buy | P | 23.48 | 80,618 | 1,892,588 | 3,258,862 | 3.2 M to 3.3 M (+2.54 %) |
Aug 03 2017 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | 10% Owner | Buy | P | 22.75 | 8,000 | 181,984 | 3,178,244 | 3.2 M to 3.2 M (+0.25 %) |
Aug 03 2017 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | 10% Owner | Buy | P | 20.95 | 17,010 | 356,274 | 3,170,244 | 3.2 M to 3.2 M (+0.54 %) |
Aug 03 2017 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | 10% Owner | Buy | P | 20.20 | 42,990 | 868,398 | 3,153,234 | 3.1 M to 3.2 M (+1.38 %) |
May 24 2017 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | 10% Owner | Buy | P | 28.07 | 2,000 | 56,148 | 3,110,244 | 3.1 M to 3.1 M (+0.06 %) |
May 24 2017 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | 10% Owner | Buy | P | 27.63 | 28,600 | 790,161 | 3,108,244 | 3.1 M to 3.1 M (+0.93 %) |
May 24 2017 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | 10% Owner | Buy | P | 26.69 | 18,600 | 496,397 | 3,079,644 | 3.1 M to 3.1 M (+0.61 %) |
May 24 2017 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | 10% Owner | Buy | P | 26.67 | 6,800 | 181,336 | 3,061,044 | 3.1 M to 3.1 M (+0.22 %) |
May 24 2017 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | 10% Owner | Buy | P | 26.15 | 27,928 | 730,289 | 3,054,244 | 3 M to 3.1 M (+0.92 %) |
May 11 2017 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | 10% Owner | Buy | P | 21.52 | 7,500 | 161,378 | 3,026,316 | 3 M to 3 M (+0.25 %) |
May 11 2017 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | 10% Owner | Buy | P | 20.55 | 10,100 | 207,545 | 3,018,816 | 3 M to 3 M (+0.34 %) |
May 11 2017 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | 10% Owner | Buy | P | 21.47 | 19,489 | 418,351 | 3,008,716 | 3 M to 3 M (+0.65 %) |
May 11 2017 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | 10% Owner | Buy | P | 20.07 | 5,000 | 100,360 | 2,989,227 | 3 M to 3 M (+0.17 %) |
May 11 2017 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | 10% Owner | Buy | P | 19.43 | 1,300 | 25,256 | 2,984,227 | 3 M to 3 M (+0.04 %) |
May 02 2017 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | 10% Owner | Buy | P | 24.00 | 35,000 | 840,000 | 35,000 | 0 to 35 K |
May 02 2017 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | 10% Owner | Buy | P | 23.40 | 5,000 | 117,000 | 2,982,927 | 3 M to 3 M (+0.17 %) |
May 02 2017 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | 10% Owner | Buy | P | 23.81 | 19,348 | 460,715 | 2,977,927 | 3 M to 3 M (+0.65 %) |
May 02 2017 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | 10% Owner | Buy | P | 23.85 | 25,000 | 596,250 | 2,958,579 | 2.9 M to 3 M (+0.85 %) |
Apr 27 2017 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | 10% Owner | Buy | P | 22.95 | 200 | 4,590 | 2,933,579 | 2.9 M to 2.9 M (+0.01 %) |
Apr 27 2017 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | 10% Owner | Buy | P | 24.47 | 10,000 | 244,690 | 2,933,379 | 2.9 M to 2.9 M (+0.34 %) |
Apr 27 2017 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | 10% Owner | Buy | P | 24.94 | 25,187 | 628,113 | 2,923,379 | 2.9 M to 2.9 M (+0.87 %) |
Apr 19 2017 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | 10% Owner | Buy | P | 25.37 | 37,905 | 961,801 | 2,898,192 | 2.9 M to 2.9 M (+1.33 %) |
Apr 19 2017 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | 10% Owner | Buy | P | 24.35 | 26,000 | 633,048 | 2,860,287 | 2.8 M to 2.9 M (+0.92 %) |
Apr 19 2017 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | 10% Owner | Buy | P | 23.28 | 53,228 | 1,239,361 | 2,834,287 | 2.8 M to 2.8 M (+1.91 %) |
Apr 19 2017 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | 10% Owner | Buy | P | 22.24 | 32,990 | 733,533 | 2,781,059 | 2.7 M to 2.8 M (+1.20 %) |
Apr 19 2017 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | 10% Owner | Buy | P | 26.02 | 28,000 | 728,588 | 2,748,069 | 2.7 M to 2.7 M (+1.03 %) |
Apr 19 2017 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | 10% Owner | Buy | P | 25.06 | 33,819 | 847,437 | 2,720,069 | 2.7 M to 2.7 M (+1.26 %) |
Apr 19 2017 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | 10% Owner | Buy | P | 25.39 | 73,900 | 1,876,173 | 2,686,250 | 2.6 M to 2.7 M (+2.83 %) |
Apr 19 2017 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | 10% Owner | Buy | P | 24.34 | 10,500 | 255,591 | 2,612,350 | 2.6 M to 2.6 M (+0.40 %) |
Apr 19 2017 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | 10% Owner | Buy | P | 23.15 | 22,900 | 530,181 | 2,601,850 | 2.6 M to 2.6 M (+0.89 %) |
Apr 10 2017 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | 10% Owner | Buy | P | 21.40 | 22,764 | 487,081 | 2,578,950 | 2.6 M to 2.6 M (+0.89 %) |
Apr 10 2017 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | 10% Owner | Buy | P | 20.38 | 9,200 | 187,450 | 2,556,186 | 2.5 M to 2.6 M (+0.36 %) |
Apr 10 2017 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | 10% Owner | Buy | P | 19.59 | 94,100 | 1,843,795 | 2,546,986 | 2.5 M to 2.5 M (+3.84 %) |
Apr 10 2017 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | 10% Owner | Buy | P | 19.70 | 44,200 | 870,873 | 2,452,886 | 2.4 M to 2.5 M (+1.84 %) |
Apr 10 2017 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | 10% Owner | Buy | P | 18.54 | 21,200 | 393,048 | 2,408,686 | 2.4 M to 2.4 M (+0.89 %) |
Mar 20 2017 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | 10% Owner | Buy | P | 23.01 | 105,486 | 2,427,127 | 2,378,486 | 2.3 M to 2.4 M (+4.64 %) |
Mar 20 2017 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | 10% Owner | Buy | P | 24.07 | 25,859 | 622,452 | 2,273,000 | 2.2 M to 2.3 M (+1.15 %) |
Mar 20 2017 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | 10% Owner | Buy | P | 24.93 | 3,500 | 87,266 | 2,247,141 | 2.2 M to 2.2 M (+0.16 %) |
Mar 20 2017 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | 10% Owner | Buy | P | 24.14 | 69,162 | 1,669,847 | 2,243,641 | 2.2 M to 2.2 M (+3.18 %) |
Mar 20 2017 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | 10% Owner | Buy | P | 22.54 | 1,120 | 25,239 | 2,174,479 | 2.2 M to 2.2 M (+0.05 %) |
Feb 22 2017 | PLSE | Pulse Biosciences, ... | DUGGAN ROBERT W | 10% Owner | Buy | P | 11.64 | 41,624 | 484,503 | 2,173,359 | 2.1 M to 2.2 M (+1.95 %) |
May 28 2015 | PCYC | PHARMACYCLICS INC | DUGGAN ROBERT W | Chairman and CEO | Sell | U | 261.25 | 170,379 | 44,511,514 | 0 | 170.4 K to 0 (-100.00 %) |
May 28 2015 | PCYC | PHARMACYCLICS INC | DUGGAN ROBERT W | Chairman and CEO | Sell | U | 261.25 | 8,404 | 2,195,545 | 0 | 8.4 K to 0 (-100.00 %) |
May 28 2015 | PCYC | PHARMACYCLICS INC | DUGGAN ROBERT W | Chairman and CEO | Sell | U | 261.25 | 8,404 | 2,195,545 | 0 | 8.4 K to 0 (-100.00 %) |
May 28 2015 | PCYC | PHARMACYCLICS INC | DUGGAN ROBERT W | Chairman and CEO | Sell | U | 261.25 | 8,404 | 2,195,545 | 0 | 8.4 K to 0 (-100.00 %) |
May 28 2015 | PCYC | PHARMACYCLICS INC | DUGGAN ROBERT W | Chairman and CEO | Sell | U | 261.25 | 8,404 | 2,195,545 | 0 | 8.4 K to 0 (-100.00 %) |
May 28 2015 | PCYC | PHARMACYCLICS INC | DUGGAN ROBERT W | Chairman and CEO | Sell | U | 261.25 | 8,404 | 2,195,545 | 0 | 8.4 K to 0 (-100.00 %) |
May 28 2015 | PCYC | PHARMACYCLICS INC | DUGGAN ROBERT W | Chairman and CEO | Sell | U | 261.25 | 21,908 | 5,723,465 | 0 | 21.9 K to 0 (-100.00 %) |
May 28 2015 | PCYC | PHARMACYCLICS INC | DUGGAN ROBERT W | Chairman and CEO | Sell | U | 261.25 | 21,908 | 5,723,465 | 0 | 21.9 K to 0 (-100.00 %) |
May 28 2015 | PCYC | PHARMACYCLICS INC | DUGGAN ROBERT W | Chairman and CEO | Sell | U | 261.25 | 21,908 | 5,723,465 | 0 | 21.9 K to 0 (-100.00 %) |
May 28 2015 | PCYC | PHARMACYCLICS INC | DUGGAN ROBERT W | Chairman and CEO | Sell | U | 261.25 | 21,908 | 5,723,465 | 0 | 21.9 K to 0 (-100.00 %) |
May 28 2015 | PCYC | PHARMACYCLICS INC | DUGGAN ROBERT W | Chairman and CEO | Sell | U | 261.25 | 21,908 | 5,723,465 | 0 | 21.9 K to 0 (-100.00 %) |
May 28 2015 | PCYC | PHARMACYCLICS INC | DUGGAN ROBERT W | Chairman and CEO | Sell | U | 261.25 | 21,908 | 5,723,465 | 0 | 21.9 K to 0 (-100.00 %) |
May 28 2015 | PCYC | PHARMACYCLICS INC | DUGGAN ROBERT W | Chairman and CEO | Sell | U | 261.25 | 21,908 | 5,723,465 | 0 | 21.9 K to 0 (-100.00 %) |
May 28 2015 | PCYC | PHARMACYCLICS INC | DUGGAN ROBERT W | Chairman and CEO | Sell | U | 261.25 | 13,225,531 | 3,455,169,974 | 0 | 13.2 M to 0 (-100.00 %) |
May 28 2015 | PCYC | PHARMACYCLICS INC | DUGGAN ROBERT W | Chairman and CEO | Gift | G | 0.00 | 4,785 | 0 | 13,225,531 | 13.2 M to 13.2 M (-0.04 %) |
May 28 2015 | PCYC | PHARMACYCLICS INC | DUGGAN ROBERT W | Chairman and CEO | Gift | G | 0.00 | 152,635 | 0 | 13,230,316 | 13.4 M to 13.2 M (-1.14 %) |
Page: 1